High-dose therapy with 90yttrium-labeled monoclonal antibody CC49: A phase I trial

Margaret Tempero, Peter Leichner, Janina Baranowska-Kortylewicz, Katherine Harrison, Sam Augustine, Jeffrey Schlom, James Anderson, James Wisecarver, David Colcher

Research output: Contribution to journalArticle

62 Scopus citations

Fingerprint Dive into the research topics of 'High-dose therapy with <sup>90</sup>yttrium-labeled monoclonal antibody CC49: A phase I trial'. Together they form a unique fingerprint.

Medicine & Life Sciences